Liposome-mediated labeling of adrenocorticotropin fragments parallels their biological activity.
To test our hypothesis that specific interactions of ACTH peptides with model lipid membranes reflect the biological importance of similar interactions on target cells, we investigated the liposome-mediated labeling of ACTH fragments with the extremely hydrophobic photolabel, 3-trifluoromethyl-3-(m-[125I]iodophenyl)diazirine. Correlations were found between the labeling rates and the agonistic and antagonistic potencies of the peptides for in vitro steroidogenesis and inhibition of a synaptosomal protein kinase. A model for the cross-reactivity between ACTH and opioid peptides is discussed.
D000305:Adrenal Cortex Hormones / Q000096:biosynthesis; D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives / Q000378:metabolism* / Q000502:physiology; D001389:Azirines; D055598:Chemical Phenomena; D002621:Chemistry; D008081:Liposomes / Q000378:metabolism*; D010446:Peptide Fragments / Q000378:metabolism* / Q000502:physiology; D011485:Protein Binding; D047428:Protein Kinase Inhibitors; D012995:Solubility; D013574:Synaptosomes / Q000201:enzymology
D000305:Adrenal Cortex Hormones; D001389:Azirines; D008081:Liposomes; D010446:Peptide Fragments; D047428:Protein Kinase Inhibitors; C033174:3-(trifluoromethyl)-3-(3-iodophenyl)diazirine; D000324:Adrenocorticotropic Hormone